Histogranin reduced brain injury after transient focal ischemia in rats

Neurosci Lett. 2006 Oct 9;406(3):211-5. doi: 10.1016/j.neulet.2006.07.048. Epub 2006 Aug 14.

Abstract

Excitatory amino acids (EAAs) play an important role during ischemic brain injury. In this study we examined the protective effect of histogranin (HN), an endogenous peptide that antagonizes excitatory amino acids-mediated activity noncompetitively, in an animal model of cerebral ischemia. Adult rats were anesthetized with chloral hydrate. Histogranin was given intracerebroventricularly before a 60-min middle cerebral artery occlusion (MCAo). Animals were examined for their locomotor activity 2 days after MCAo. Histogranin significantly increased locomotor activity in the stroke rats. Histogranin pretreatment reduced the volume of cerebral infarction and the caspase-3 immunoreactivity in the stroke animals. Taken together, our data suggest that histogranin is protective against ischemic brain injury. The protective effect may involve anti-apoptotic mechanisms.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Behavior, Animal
  • Brain Injuries / drug therapy*
  • Brain Injuries / etiology
  • Brain Injuries / physiopathology
  • Caspase 3
  • Caspases / metabolism
  • Disease Models, Animal
  • Excitatory Amino Acid Antagonists / therapeutic use*
  • Functional Laterality
  • Ischemic Attack, Transient / complications
  • Male
  • Motor Activity / drug effects
  • Proteins / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley
  • Tetrazolium Salts

Substances

  • Excitatory Amino Acid Antagonists
  • Proteins
  • Tetrazolium Salts
  • histogranin
  • triphenyltetrazolium
  • Casp3 protein, rat
  • Caspase 3
  • Caspases